Latest On Viemed Healthcare, Inc (VMD):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 12:15 EST | News | Viemed Healthcare: Superb Growth Expectations, Reiterate Buy | N/A |  |
| 2023-05-09 19:33 EST | News | Viemed Healthcare GAAP EPS of $0.04 misses by $0.01, revenue of $39.56M beats by $1.09M | N/A | |
| 2023-05-09 19:32 EST | News | Viemed Healthcare, Inc. (VMD) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-04-18 16:18 EST | News | Viemed Healthcare agrees to acquire Tennessee-based Home Medical Products | N/A | |
| 2023-03-03 13:17 EST | News | Viemed Healthcare, Inc. (VMD) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-02 23:09 EST | News | Viemed Healthcare Q4 results mixed | N/A | |
| 2023-02-22 05:49 EST | News | Viemed Healthcare: Steady As She Goes | N/A | |
| 2023-01-12 15:22 EST | News | Viemed on the rise following $2M investment in ModoHealth | N/A | |
| 2022-11-30 07:47 EST | News | Viemed Healthcare enters into new syndicated credit facilities | N/A | |
| 2022-11-22 09:51 EST | News | Viemed Healthcare: Revising Case To Buy | N/A | |
| 2022-11-03 00:38 EST | News | Viemed Healthcare, Inc. (VMD) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-01 17:03 EST | News | Viemed Healthcare GAAP EPS of $0.03 misses by $0.01, revenue of $35.8M beats by $1M | N/A | |
| 2022-11-01 01:11 EST | News | Viemed Healthcare Q3 2022 Earnings Preview | N/A | |
| 2022-08-25 19:51 EST | News | Viemed Healthcare: Comments On Q2 Earnings | N/A | |
| 2022-08-04 03:13 EST | News | Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-02 22:21 EST | News | Viemed Healthcare GAAP EPS of $0.02 misses by $0.03, revenue of $33.1M beats by $0.8M | N/A | |
| 2022-08-02 07:13 EST | News | Viemed Healthcare Q2 2022 Earnings Preview | N/A | |
| 2022-05-08 05:30 EST | News | Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 22:05 EST | News | Viemed Healthcare GAAP EPS of $0.04 misses by $0.01, revenue of $32.25M beats by $1.12M | N/A | |
| 2022-05-03 22:05 EST | News | Viemed Healthcare GAAP EPS of $0.04 misses by $0.01, revenue of $32.26M beats by $1.13M | N/A | |
| 2022-05-03 04:01 EST | News | Viemed Healthcare Q1 2022 Earnings Preview | N/A | |
| 2022-03-08 21:26 EST | News | Viemed Healthcare GAAP EPS of $0.10 beats by $0.04, revenue of $31.96M beats by $2.23M | N/A | |
| 2022-03-08 21:25 EST | News | Viemed Healthcare announces share buyback plan | N/A | |
| 2022-03-08 21:25 EST | News | Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-08 03:35 EST | News | Viemed Healthcare GAAP EPS of $0.10 misses by $0.13, revenue of $31.96M misses by $82.87M | N/A | |
| 2021-12-30 03:13 EST | News | Viemed Healthcare: New Bullish Trend Has Just Begun | N/A | |
| 2021-11-24 07:38 EST | News | Viemed Healthcare (VMD) Investor Presentation | N/A | |
| 2021-11-10 17:58 EST | News | Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-02 05:49 EST | News | Viemed Healthcare 3Q 2021 Earnings Preview | N/A | |
| 2021-11-02 05:49 EST | News | Viemed Healthcare EPS in-line, beats on revenue | N/A | |
| 2021-11-02 05:49 EST | News | Viemed Healthcare EPS misses by $0.01, beats on revenue; issues Q4 guidance | N/A | |
| 2021-08-04 17:23 EST | News | Viemed Healthcare's (VMD) CEO Casey Hoyt on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-03 01:38 EST | News | Viemed Healthcare EPS beats by $0.01, beats on revenue | N/A | |
| 2021-05-06 21:10 EST | News | Viemed Healthcare, Inc. 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-05-04 07:40 EST | News | Viemed Healthcare EPS misses by $0.01, revenue in-line | N/A | |
| 2021-04-19 19:01 EST | News | Cove Street Capital Discusses Viemed | N/A | |
| 2021-03-07 04:37 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-05 07:46 EST | News | Viemed Healthcare EPS beats by $0.07, beats on revenue | N/A | |
| 2021-03-04 10:57 EST | News | Viemed Healthcare, Inc. (VMD) CEO Casey Hoyt on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-04 04:49 EST | Financials | Company financials have been released. | Neutral | |
| 2021-01-12 00:23 EST | News | Strong Execution By Insider-Owners Ensures Viemed's Growth | N/A | |
| 2020-11-26 21:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 22:14 EST | News | Viemed Healthcare, Inc.'s (VMD) CEO Casey Hoyt on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-08 01:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 21:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-05 18:18 EST | News | Viemed Healthcare EPS misses by $0.02, beats on revenue | N/A | |
| 2020-09-26 14:30 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:53 EST | News | Viemed: A Healthcare Stock To Watch | N/A | |
| 2020-09-17 06:35 EST | Financials | Company financials have been released. | Neutral | |
About Viemed Healthcare, Inc (VMD):
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.
General
- Name Viemed Healthcare, Inc
- Symbol VMD
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 511
- Fiscal Year EndDecember
- IPO Date2017-12-22
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Providers & Services
- Web URLhttp://www.viemed.com
View More
Valuation
- Trailing PE 36.64
- Forward PE 39.84
- Price/Sales (Trailing 12 Mt.) 3.19
- Price/Book (Most Recent Quarter) 5.01
- Enterprise Value Revenue 2.93
- Enterprise Value EBITDA 10.55
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 24%
- Operating Margin 16%
- Return on Assets 13%
- Return on Equity 50%
- Revenue 131.31 million
- Earnings Per Share $0.25
- Revenue Per Share $3.39
- Gross Profit 80.11 million
- Quarterly Earnings Growth 45.5%
View More
Highlights
- Market Capitalization 360.09 million
- EBITDA 30.54 million
- PE Ratio 31.44
- Book Value Per Share $1.15
View More
Share Statistics
- Shares Outstanding 39.56 million
- Shares Float 35.06 million
- % Held by Insiders 1142%
- % Held by Institutions 55.79%
- Shares Short 1.35 million
- Shares Short Prior Month 1.28 million
- Short Ratio 6.18
- Short % of Float 4%
- Short % of Shares Outstanding 3%
View More
Technicals
- Beta 0.78
- 52 Week High $11.93
- 52 Week Low $3.52
- 50 Day Moving Average 9.85
- 200 Day Moving Average 9.1
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Viemed Healthcare, Inc (VMD) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Viemed Healthcare, Inc (VMD) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-03 | $N/A | $0.12 | $0.05 | 125.14% |
| 2020-09-30 | 2020-11-04 | $N/A | $0.07 | $0.09 | -17.65% |
| 2020-06-30 | 2020-08-04 | $42.85 million | $0.48 | $0.26 | 84.62% |
| 2020-03-31 | 2020-05-04 | $23.81 million | $0.11 | $0.08 | 37.5% |
| 2019-12-31 | 2020-03-03 | $13.74 million | $0.06 | $0.07 | -14.29% |
| 2019-09-30 | 2019-11-04 | $23.53 million | $0.07 | $0.06 | 16.67% |
| 2019-06-30 | 2019-08-09 | $22.55 million | $0.05 | $0.06 | -16.67% |
| 2019-03-31 | 2019-05-06 | $20.44 million | $0.05 | $0.08 | -37.5% |
| 2018-12-31 | 2019-02-27 | $18.49 million | $0.08 | $0.08 | 0% |
| 2018-09-30 | 2018-11-05 | $17.16 million | $0.06 | $0.06 | 0% |
| 2018-06-30 | 2018-08-13 | $15.51 million | $0.06 | ||
| 2018-03-31 | 2018-05-07 | $14.11 million | $0.06 |
Viemed Healthcare, Inc (VMD) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 271000 | 174000 | 203000 |
| Income Before Tax | N/A | N/A | 12.77 million | 4.43 million | 1.65 million |
| Selling General Administrative | N/A | N/A | 17.62 million | 11.73 million | 3.26 million |
| Gross Profit | N/A | N/A | 25.93 million | 15.55 million | 6.54 million |
| Ebit | N/A | N/A | 15.09 million | 6.72 million | 1.91 million |
| Operating Income | N/A | N/A | 7.83 million | 3.45 million | 1.91 million |
| Income Tax Expense | 151000 | 1.14 million | -6.65 million | 187000 | 58000 |
| Total Revenue | N/A | N/A | 42.85 million | 23.81 million | 13.74 million |
| Cost of Revenue | N/A | N/A | 16.93 million | 8.25 million | 7.21 million |
| Total Other Income Expense Net | N/A | N/A | 5.07 million | 1.14 million | -264000 |
| Net Income From Continuing Operations | N/A | N/A | 19.41 million | 4.24 million | 1.59 million |
| Net Income Applicable to Common Shares | 5.07 million | 2.8 million | 19.41 million | 4.24 million | 1.59 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | 1.09 million | -1.71 million | N/A | N/A |
| Change to Liabilities | 1.03 million | -1.67 million | 3.68 million | 3.32 million | -3.75 million |
| Total Cash Flow from Investing Activities | -2.43 million | 1.09 million | -1.71 million | -2.58 million | -2.75 million |
| Net Borrowings | -2.22 million | -2.93 million | -3.86 million | -4.1 million | 1.6 million |
| Total Cash Flow from Financial Activities | N/A | -1.17 million | -3.84 million | -4.1 million | 1.96 million |
| Change to Operating Activities | -2.81 million | 8.75 million | -5.31 million | 1.2 million | 877000 |
| Change in Cash | N/A | 21.3 million | -4.95 million | 725000 | 4.94 million |
| Total Cash from Operating Activities | 7.33 million | 21.38 million | 607000 | 7.4 million | 5.72 million |
| Depreciation | N/A | 2.19 million | 2.13 million | 2 million | 1.66 million |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | -4.8 million | -425000 | -1.93 million | 2.45 million |
| Change to Account Receivables | N/A | 1.68 million | -6.76 million | -2.68 million | -2.01 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 3.1 million | -5.4 million | 2.86 million | 3.83 million | 3.51 million |
| Capital Expenditures | N/A | 1.51 million | 4.22 million | 2.8 million | 2.88 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 30.87 million | N/A | 41.05 million | 38.01 million | 38.9 million |
| Total Stockholder Equity | 81.69 million | N/A | 71.13 million | 48.8 million | 43.7 million |
| Other Current Liabilities | 6.15 million | 3.98 million | N/A | N/A | 3.4 million |
| Total Assets | 112.56 million | N/A | 112.18 million | 86.8 million | 82.6 million |
| Common Stock | 9.18 million | 9.09 million | 8.41 million | 6.66 million | 3.37 million |
| Other Current Assets | 1.51 million | N/A | N/A | N/A | N/A |
| Retained Earnings | 65.64 million | 60.57 million | 57.77 million | 38.36 million | 34.11 million |
| Other Liabilities | N/A | 1.21 million | 1.03 million | 2.35 million | 2.12 million |
| Other Assets | N/A | 7.59 million | 7.83 million | 18000 | 13000 |
| Cash | 30.98 million | N/A | 29.71 million | 8.41 million | 13.36 million |
| Total Current Liabilities | 23.02 million | 30.35 million | 31.77 million | 26.15 million | 25.91 million |
| Other Stockholder Equity | -451000 | -478000 | -502000 | -469000 | -157000 |
| Property, Plant & Equipment | 55.06 million | 56.32 million | 55.09 million | 56.63 million | 54.77 million |
| Total Current Assets | 47.18 million | 49.98 million | 49.21 million | 30.15 million | 27.81 million |
| Long Term Investments | 733000 | N/A | 59000 | 18000 | N/A |
| Net Tangible Assets | 81.69 million | 75.2 million | 71.13 million | 48.8 million | 43.7 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | 5.8 million | N/A | 6.72 million | 7.18 million | 7.83 million |
| Inventory | 2.31 million | 2.76 million | 6.58 million | 1.79 million | 1.36 million |
| Accounts Payable | 15.03 million | 7.55 million | 9.27 million | 7.16 million | 4.7 million |
Viemed Healthcare, Inc (VMD) Chart:
Viemed Healthcare, Inc (VMD) News:
Below you will find a list of latest news for Viemed Healthcare, Inc (VMD) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Viemed Healthcare, Inc (VMD) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 4.9 | CALL | 0 | 7 | 565.51 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 191.8 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 2.8 | CALL | 0 | 20 | 57.35 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0.15 | CALL | 0 | 141 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 60.32 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 117.82 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 0 | PUT | 0 | 0 | 200.83 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 0 | PUT | 0 | 0 | 414.76 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 0 | PUT | 0 | 0 | 148.62 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | CALL | 0 | 0 | 219.79 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 3.78 | CALL | 0 | 7 | 107.15 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 3.31 | CALL | 0 | 11 | 43.58 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 0.26 | CALL | 0 | 5 | 41.16 | FALSE | 0 | 0 |
| 2024-08-16 | 12.5 | 0.3 | CALL | 0 | 63 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.12 | PUT | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 41.65 | FALSE | 0 | 0 |
| 2024-08-16 | 10 | 1.65 | PUT | 0 | 2 | 74.93 | TRUE | 0 | 0 |
| 2024-08-16 | 12.5 | 0 | PUT | 0 | 0 | 88.83 | TRUE | 0 | 0 |
| 2024-08-16 | 15 | 0 | PUT | 0 | 0 | 128.23 | TRUE | 0 | 0 |
| 2024-08-16 | 17.5 | 0 | PUT | 0 | 0 | 135.62 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 123.56 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 71.41 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 44.19 | TRUE | 0 | 0 |
| 2024-11-15 | 10 | 0.61 | CALL | 0 | 1 | 45.76 | FALSE | 0 | 0 |
| 2024-11-15 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 15 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 0.55 | PUT | 0 | 3 | 38.75 | FALSE | 0 | 0 |
| 2024-11-15 | 10 | 1.85 | PUT | 0 | 1 | 39.63 | TRUE | 0 | 0 |
| 2024-11-15 | 12.5 | 0 | PUT | 0 | 0 | 93.23 | TRUE | 0 | 0 |
| 2024-11-15 | 15 | 0 | PUT | 0 | 0 | 61.12 | TRUE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | PUT | 0 | 0 | 82.1 | TRUE | 0 | 0 |
Latest VMD Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 200 | $5.695 |
| Jun 13, 2022 7:59 PM EST | 400 | $5.7 |
| Jun 13, 2022 7:59 PM EST | 200 | $5.695 |
| Jun 13, 2022 7:59 PM EST | 100 | $5.705 |
| Jun 13, 2022 7:59 PM EST | 9 | $5.7 |
Viemed Healthcare, Inc (VMD) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000033/0001729149-20-000033-index.htm |
| 2019-05-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1729149/000000000019009166/0000000000-19-009166-index.htm |
| 2020-09-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1729149/000000000020008400/0000000000-20-008400-index.htm |
| 2020-01-15 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1729149/000091384920000009/0000913849-20-000009-index.htm |
| 2019-05-03 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1729149/000114036119008363/0001140361-19-008363-index.htm |
| 2019-06-26 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1729149/000114036119011692/0001140361-19-011692-index.htm |
| 2019-06-26 | DRSLTR | Correspondence Related to Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1729149/000114036119011697/0001140361-19-011697-index.htm |
| 2019-07-10 | 10-12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1729149/000114036119012755/0001140361-19-012755-index.htm |
| 2019-07-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1729149/000114036119013442/0001140361-19-013442-index.htm |
| 2019-08-01 | 10-12B/A | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1729149/000114036119014025/0001140361-19-014025-index.htm |
| 2019-08-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1729149/000114036119014437/0001140361-19-014437-index.htm |
| 2019-08-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1729149/000114036119014466/0001140361-19-014466-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000114036119014661/0001140361-19-014661-index.htm |
| 2019-08-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1729149/000114036119015469/0001140361-19-015469-index.htm |
| 2019-08-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1729149/000114036119015470/0001140361-19-015470-index.htm |
| 2019-09-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000114036119016991/0001140361-19-016991-index.htm |
| 2020-09-03 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1729149/000114036120019719/0001140361-20-019719-index.htm |
| 2020-09-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1729149/000114036120019947/0001140361-20-019947-index.htm |
| 2018-02-01 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1729149/000118374018000020/0001183740-18-000020-index.htm |
| 2019-08-07 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1729149/000135445719000402/0001354457-19-000402-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1729149/000172914919000005/0001729149-19-000005-index.htm |
| 2019-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914919000008/0001729149-19-000008-index.htm |
| 2019-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914919000010/0001729149-19-000010-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914919000012/0001729149-19-000012-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1729149/000172914919000016/0001729149-19-000016-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000002/0001729149-20-000002-index.htm |
| 2020-03-04 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000005/0001729149-20-000005-index.htm |
| 2020-03-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000008/0001729149-20-000008-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000011/0001729149-20-000011-index.htm |
| 2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000013/0001729149-20-000013-index.htm |
| 2020-04-28 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000015/0001729149-20-000015-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000017/0001729149-20-000017-index.htm |
| 2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000019/0001729149-20-000019-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000021/0001729149-20-000021-index.htm |
| 2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000023/0001729149-20-000023-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000026/0001729149-20-000026-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000029/0001729149-20-000029-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000031/0001729149-20-000031-index.htm |
| 2020-06-19 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000033/0001729149-20-000033-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000035/0001729149-20-000035-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000038/0001729149-20-000038-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000040/0001729149-20-000040-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000047/0001729149-20-000047-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000049/0001729149-20-000049-index.htm |
| 2020-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1729149/000172914920000052/0001729149-20-000052-index.htm |
| 2020-09-10 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1729149/999999999520002416/9999999995-20-002416-index.htm |
| 2019-08-08 | SEC STAFF | SEC Staff Action: ORDER | https://www.sec.gov/Archives/edgar/data/1729149/999999999719006414/9999999997-19-006414-index.htm |